Cornell: Study Reveals Potential Therapies for Aggressive Lymphoma
May 27, 2022
May 27, 2022
ITHACA, New York, May 27 (TNSjou) -- Cornell University issued the following news:
By Bridget Kuehn
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively can recognize a vast number of specific targets. But this process can go awry in people with a mutation in a gene called SETD2, leading to a type of aggressive blood cancer, according to a study by Weill Cornell Medicine investigators.
. . .
By Bridget Kuehn
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells called B cells that collectively can recognize a vast number of specific targets. But this process can go awry in people with a mutation in a gene called SETD2, leading to a type of aggressive blood cancer, according to a study by Weill Cornell Medicine investigators.
. . .